From: Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients
n, median (min–max) | % | |
---|---|---|
Sex | ||
Male | 64 | 59.3 |
Female | 44 | 40.7 |
Age (years) | 41 (22–87) | |
< 41 | 53 | 49.1 |
≥ 41 | 55 | 50.9 |
KPS (%) | 90 (60–100) | |
< 90 | 25 | 23.1 |
≥ 90 | 69 | 63.9 |
Unknown | 14 | 13.0 |
IDH | ||
Mutant | 84 | 77.8 |
Wildtype | 9 | 8.3 |
Unknown | 15 | 13.9 |
MGMT | ||
Methylated | 86 | 79.6 |
Non-methylated | 19 | 17.6 |
Unknown | 3 | 2.8 |
1p/19q-Codeletion | ||
Non-codeleted | 108 | 100.0 |
Codeleted | 0 | 0.0 |
Unknown | 0 | 0.0 |
Resection | ||
Biopsy | 13 | 12.0 |
Subtotal resection | 25 | 23.1 |
Gross total resection | 65 | 60.2 |
Unknown | 5 | 4.6 |
Treatment after surgery | ||
CTx mono | 48 | 44.4 |
RT mono | 8 | 7.4 |
RT + concCTx | 5 | 4.6 |
RT + adjCTx | 5 | 4.6 |
RT + concCTx + adjCTx | 20 | 18.5 |
RT, CTx unknown | 6 | 5.6 |
No RT, CTx unknown | 3 | 2.8 |
Unknown | 13 | 12.0 |